![]() |
Volumn 15 Suppl 1, Issue , 2010, Pages 73-79
|
Of value: A discussion of cost, communication, and evidence to improve cancer care.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BIOETHICS;
COST OF ILLNESS;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
EVIDENCE BASED MEDICINE;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE QUALITY;
HUMAN;
INTERDISCIPLINARY COMMUNICATION;
LEGAL ASPECT;
MORTALITY;
NEOPLASM;
ORGANIZATION;
PATIENT ADVOCACY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
SURVIVAL;
UNITED STATES;
BIOETHICAL ISSUES;
CALIFORNIA;
CONGRESSES AS TOPIC;
COST OF ILLNESS;
DRUG COSTS;
DRUG INDUSTRY;
EVIDENCE-BASED MEDICINE;
HEALTH CARE COSTS;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INSTITUTE OF MEDICINE (U.S.);
INTERDISCIPLINARY COMMUNICATION;
NEOPLASMS;
PATIENT ADVOCACY;
QUALITY OF HEALTH CARE;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SURVIVAL ANALYSIS;
UNITED STATES;
|
EID: 77954465818
PISSN: None
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2010-S1-73 Document Type: Article |
Times cited : (20)
|
References (0)
|